Insider · CIK 0001185035

NOYES TIMOTHY P

Reports to the SEC for 2 companies · WALTHAM, MA

sec.gov

Transactions

Companies

Filings

CIK

0001185035

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2024-05-16	JBIOJade Biosciences, Inc.M Exercise/Conversion	Director, CHIEF EXECUTIVE OFFICER	MExercise/Conversion	+10K sh	$2.14	+$21.4K	10,000
2024-05-16	JBIOJade Biosciences, Inc.S Sale	Director, CHIEF EXECUTIVE OFFICER	SSale	−8,707 sh	$21.52	−$187K	1,293
2024-05-16	JBIOJade Biosciences, Inc.S Sale	Director, CHIEF EXECUTIVE OFFICER	SSale	−1,293 sh	$21.92	−$28.3K	0
2024-05-16	JBIOJade Biosciences, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director, CHIEF EXECUTIVE OFFICER	MExercise/Conversion	−10K sh	—	—	343,381
2024-05-01	JBIOJade Biosciences, Inc.M Exercise/Conversion	Director, CHIEF EXECUTIVE OFFICER	MExercise/Conversion	+10K sh	$2.14	+$21.4K	10,000
2024-05-01	JBIOJade Biosciences, Inc.S Sale	Director, CHIEF EXECUTIVE OFFICER	SSale	−9,035 sh	$20.34	−$184K	965
2024-05-01	JBIOJade Biosciences, Inc.S Sale	Director, CHIEF EXECUTIVE OFFICER	SSale	−965 sh	$20.87	−$20.1K	0
2024-05-01	JBIOJade Biosciences, Inc.S Sale	Director, CHIEF EXECUTIVE OFFICER	SSale	−1,357 sh	$19.91	−$27K	0
2024-05-01	JBIOJade Biosciences, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director, CHIEF EXECUTIVE OFFICER	MExercise/Conversion	−10K sh	—	—	353,381
2024-04-16	JBIOJade Biosciences, Inc.M Exercise/Conversion	Director, CHIEF EXECUTIVE OFFICER	MExercise/Conversion	+10K sh	$2.14	+$21.4K	10,000
2024-04-16	JBIOJade Biosciences, Inc.S Sale	Director, CHIEF EXECUTIVE OFFICER	SSale	−4,491 sh	$24.40	−$110K	5,509
2024-04-16	JBIOJade Biosciences, Inc.S Sale	Director, CHIEF EXECUTIVE OFFICER	SSale	−5,509 sh	$24.94	−$137K	0
2024-04-16	JBIOJade Biosciences, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director, CHIEF EXECUTIVE OFFICER	MExercise/Conversion	−10K sh	—	—	363,381
2024-04-01	JBIOJade Biosciences, Inc.M Exercise/Conversion	Director, CHIEF EXECUTIVE OFFICER	MExercise/Conversion	+10K sh	$2.14	+$21.4K	10,000
2024-04-01	JBIOJade Biosciences, Inc.S Sale	Director, CHIEF EXECUTIVE OFFICER	SSale	−4,502 sh	$28.96	−$130K	5,498
2024-04-01	JBIOJade Biosciences, Inc.S Sale	Director, CHIEF EXECUTIVE OFFICER	SSale	−1,647 sh	$29.90	−$49.2K	3,851
2024-04-01	JBIOJade Biosciences, Inc.S Sale	Director, CHIEF EXECUTIVE OFFICER	SSale	−2,851 sh	$31.02	−$88.4K	1,000
2024-04-01	JBIOJade Biosciences, Inc.S Sale	Director, CHIEF EXECUTIVE OFFICER	SSale	−1,000 sh	$31.95	−$32K	0
2024-04-01	JBIOJade Biosciences, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director, CHIEF EXECUTIVE OFFICER	MExercise/Conversion	−10K sh	—	—	373,381
2024-01-29	JBIOJade Biosciences, Inc. · Stock Option (Right to Buy)A Award	Director, CHIEF EXECUTIVE OFFICER	AAward	+200K sh	—	—	200,000
2023-11-01	JBIOJade Biosciences, Inc.S Sale	Director, CHIEF EXECUTIVE OFFICER	SSale	−1,092 sh	$10.42	−$11.4K	0
2023-07-28	JBIOJade Biosciences, Inc.M Exercise/Conversion	Director, CHIEF EXECUTIVE OFFICER	MExercise/Conversion	+5,478 sh	$2.14	+$11.7K	5,478
2023-07-28	JBIOJade Biosciences, Inc.S Sale	Director, CHIEF EXECUTIVE OFFICER	SSale	−5,478 sh	$18.00	−$98.6K	0
2023-07-28	JBIOJade Biosciences, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director, CHIEF EXECUTIVE OFFICER	MExercise/Conversion	−5,478 sh	—	—	383,381
2023-07-17	JBIOJade Biosciences, Inc.M Exercise/Conversion	Director, CHIEF EXECUTIVE OFFICER	MExercise/Conversion	+4,522 sh	$2.14	+$9,677.08	4,522
2023-07-17	JBIOJade Biosciences, Inc.S Sale	Director, CHIEF EXECUTIVE OFFICER	SSale	−4,522 sh	$18.11	−$81.9K	0
2023-07-17	JBIOJade Biosciences, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director, CHIEF EXECUTIVE OFFICER	MExercise/Conversion	−4,522 sh	—	—	388,859
2023-07-03	JBIOJade Biosciences, Inc.M Exercise/Conversion	Director, CHIEF EXECUTIVE OFFICER	MExercise/Conversion	+10K sh	$2.14	+$21.4K	10,000
2023-07-03	JBIOJade Biosciences, Inc.S Sale	Director, CHIEF EXECUTIVE OFFICER	SSale	−10K sh	$18.00	−$180K	0
2023-07-03	JBIOJade Biosciences, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director, CHIEF EXECUTIVE OFFICER	MExercise/Conversion	−10K sh	—	—	393,381
2023-05-02	JBIOJade Biosciences, Inc.S Sale	Director, CHIEF EXECUTIVE OFFICER	SSale	−693 sh	$21.15	−$14.7K	0
2023-05-01	JBIOJade Biosciences, Inc.M Exercise/Conversion	Director, CHIEF EXECUTIVE OFFICER	MExercise/Conversion	+15K sh	$2.14	+$32.1K	15,693
2023-05-01	JBIOJade Biosciences, Inc.S Sale	Director, CHIEF EXECUTIVE OFFICER	SSale	−15K sh	$20.61	−$309K	693
2023-05-01	JBIOJade Biosciences, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director, CHIEF EXECUTIVE OFFICER	MExercise/Conversion	−15K sh	—	—	403,381
2023-04-03	JBIOJade Biosciences, Inc.M Exercise/Conversion	Director, CHIEF EXECUTIVE OFFICER	MExercise/Conversion	+15K sh	$2.14	+$32.1K	15,000
2023-04-03	JBIOJade Biosciences, Inc.S Sale	Director, CHIEF EXECUTIVE OFFICER	SSale	−9,172 sh	$19.16	−$176K	5,828
2023-04-03	JBIOJade Biosciences, Inc.S Sale	Director, CHIEF EXECUTIVE OFFICER	SSale	−5,828 sh	$19.77	−$115K	0
2023-04-03	JBIOJade Biosciences, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director, CHIEF EXECUTIVE OFFICER	MExercise/Conversion	−15K sh	—	—	418,381
2023-03-07	JBIOJade Biosciences, Inc. · Stock Option (Right to Buy)A Award	Director, CHIEF EXECUTIVE OFFICER	AAward	+139K sh	—	—	139,067
2023-03-01	JBIOJade Biosciences, Inc.M Exercise/Conversion	Director, CHIEF EXECUTIVE OFFICER	MExercise/Conversion	+15K sh	$2.14	+$32.1K	15,000
2023-03-01	JBIOJade Biosciences, Inc.S Sale	Director, CHIEF EXECUTIVE OFFICER	SSale	−5,962 sh	$22.71	−$135K	9,038
2023-03-01	JBIOJade Biosciences, Inc.S Sale	Director, CHIEF EXECUTIVE OFFICER	SSale	−2,672 sh	$23.81	−$63.6K	6,366
2023-03-01	JBIOJade Biosciences, Inc.S Sale	Director, CHIEF EXECUTIVE OFFICER	SSale	−5,316 sh	$24.69	−$131K	1,050
2023-03-01	JBIOJade Biosciences, Inc.S Sale	Director, CHIEF EXECUTIVE OFFICER	SSale	−1,050 sh	$25.67	−$27K	0
2023-03-01	JBIOJade Biosciences, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director, CHIEF EXECUTIVE OFFICER	MExercise/Conversion	−15K sh	—	—	433,381
2023-02-01	JBIOJade Biosciences, Inc.M Exercise/Conversion	Director, CHIEF EXECUTIVE OFFICER	MExercise/Conversion	+15K sh	$2.14	+$32.1K	15,000
2023-02-01	JBIOJade Biosciences, Inc.S Sale	Director, CHIEF EXECUTIVE OFFICER	SSale	−10.5K sh	$22.52	−$237K	4,495
2023-02-01	JBIOJade Biosciences, Inc.S Sale	Director, CHIEF EXECUTIVE OFFICER	SSale	−4,495 sh	$23.05	−$104K	0
2023-02-01	JBIOJade Biosciences, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director, CHIEF EXECUTIVE OFFICER	MExercise/Conversion	−15K sh	—	—	448,381
2023-01-03	JBIOJade Biosciences, Inc.M Exercise/Conversion	Director, CHIEF EXECUTIVE OFFICER	MExercise/Conversion	+15K sh	$2.14	+$32.1K	15,000

Recent filings

Accepted (ET)
May 174
NOYES TIMOTHY P0001415889-24-013629
SEC(opens sec.gov)
May 34
NOYES TIMOTHY P0001415889-24-012234
SEC(opens sec.gov)
Apr 184
NOYES TIMOTHY P0001415889-24-011144
SEC(opens sec.gov)
Apr 34
NOYES TIMOTHY P0001415889-24-010138
SEC(opens sec.gov)
Jan 314
NOYES TIMOTHY P0001415889-24-002089
SEC(opens sec.gov)

Companies

Address

C/O PROTEON THERAPEUTICS 200 WEST STREET

WALTHAM, MA, 02451